|
|
Johnson and Johnson (NYSE: JNJ) |
|
JNJ's Dividend Pay out ratio over the 12 Months Period
Cumulative by Quarter, Trailing twelve months
Due to increase in earnings per share in the first quarter 2025, Johnson And Johnson's 12 Months dividend pay out ratio sequentially decreased to 54.66% in the first quarter 2025, otherwise the ratio remained above the average, as JNJ's cash flow remains strong.
Within Healthcare sector 10 other companies have achieved higher 12 Months dividend pay out ratio. While in terms of ranking among all other companies, the company has moved form 94 in the fourth quarter 2024, to 453.
Dividend in Glossary
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| Cumulative Dividend Pay out Ratio |
I. Quarter
(Mar 30 2025) |
IV. Quarter
(Dec 29 2024) |
III. Quarter
(Sep 29 2024) |
II. Quarter
(Jun 30 2024) |
I. Quarter
(Mar 31 2024) |
| JNJ's Pay out Ratio (TTM) |
54.66 % |
83.89 % |
78.52 % |
30.71 % |
30.3 % |
| JNJ's Dividend Pay out Ratio Total
Ranking |
# 453 |
# 94 |
# 64 |
# 497 |
# 368 |
News about Johnson and Johnson Dividends |
|
Johnson and Johnson Announces Quarterly Dividend for Third Quarter 2024 Amidst Declining Stock Performance
In the recent press release from Johnson and Johnson, the company has declared a cash dividend for the third quarter of 2024 of $1.24 per share on the company's common stock. This announcement comes after a period of declining stock performance, as highlighted in the previous press release titled Johnson and Johnson Declares Quarterly Dividend Amidst Declining Stock Performance on October 19, 2023.
As of the first quarter of 2024, Johnson and Johnson's 12 Months dividend pay out ratio decreased to 30.3%, remaining above the company's average of 13.96%. When compared to its peers in the Healthcare sector, 25 companies had a higher 12 Months dividend pay out ratio. Additionally, in terms of ranking among all other companies, Johnson and Johnson has moved from 237 in the fourth quarter of 2023 to 368.
|
|
Johnson and Johnson (NYSE: JNJ) recently announced that its Board of Directors has approved a cash dividend of $1.19 per share for the fourth quarter of 2023. This dividend will be paid out on December 5, 2023, to shareholders of record as of November 21, 2023. However, this news comes at a crucial time for the company, as its stock performance has been steadily declining.
Over the past seven days, Johnson and Johnson's stock has witnessed a decline of -2.3%. This downward trend has further contributed to a year-to-date performance of -14.29%. Despite these statistics, it is worth noting that Johnson and Johnson's stock currently trades 1.7% above its 52-week low.
|
|
NEW BRUNSWICK, N.J. - Johnson and Johnson, a leading healthcare company, unveiled its robust results for the third quarter of 2023. The company's CEO, Joaquin Duato, praised the strong performance and significant advancements in the company's pipeline, highlighting a promising future for sustained growth. With a dedicated focus on Innovative Medicine and MedTech solutions, Johnson and Johnson continues to revolutionize the healthcare landscape.
The impact of this news on shareholders has been intriguing. Over the past five days, Johnson and Johnson's shares experienced a slight decline of -0.52%. However, when placed in the context of the broader picture, the year-to-date performance shows a more significant decrease of -11.59%. It is important to note that despite the recent stock dip, the company's shares still trade 4.9% above its 52-week low.
|
| Dividend Pay out Ratio Statistics |
| High |
Average |
Low |
| 706.43 % |
16.62 % |
-4913.69 % |
| (Apr 01 2018) |
|
(Dec 29 2013) |
|
